News &
Events

news

4

June

2019

RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2 Positive Metastatic or Unresectable Urothelial Cancer

16

May

2019

RemeGen, Ltd. Highlights New Data to be Presented at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

For media inquiries, please contact Jennifer Gordon at

jgordon@spectrumscience.com